Publication:
Belimumab in Lupus Nephritis: New Trial Results Arrive During an Exciting Time for Therapeutics.

Simple item page
dc.contributor.authorOliva-Damaso, Nestor
dc.contributor.authorBomback, Andrew S
dc.date.accessioned2023-02-09T10:37:37Z
dc.date.available2023-02-09T10:37:37Z
dc.date.issued2020-11-20
dc.identifier.doi10.1053/j.ajkd.2020.11.003
dc.identifier.essn1523-6838
dc.identifier.pmid33221369
dc.identifier.unpaywallURLhttp://www.ajkd.org/article/S0272638620311240/pdf
dc.identifier.urihttp://hdl.handle.net/10668/16642
dc.issue.number6
dc.journal.titleAmerican journal of kidney diseases : the official journal of the National Kidney Foundation
dc.journal.titleabbreviationAm J Kidney Dis
dc.language.isoen
dc.organizationHospital Costa del Sol
dc.page.number984-987
dc.pubmedtypeEditorial
dc.rights.accessRightsopen access
dc.subject.meshAntibodies, Monoclonal, Humanized
dc.subject.meshClinical Trials, Phase III as Topic
dc.subject.meshDouble-Blind Method
dc.subject.meshHumans
dc.subject.meshLupus Nephritis
dc.subject.meshMulticenter Studies as Topic
dc.subject.meshRandomized Controlled Trials as Topic
dc.subject.meshTreatment Outcome
dc.titleBelimumab in Lupus Nephritis: New Trial Results Arrive During an Exciting Time for Therapeutics.
dc.typeresearch article
dc.type.hasVersionVoR
dc.volume.number77
dspace.entity.typePublication

Files

Collections

SAS - Hospital Costa del Sol

© 2023 – Repositorio Institucional de Salud de Andalucía - Fundación Pública Andaluza Progreso y Salud - Consejería de Salud y Consumo de la Junta de Andalucía